Referencias


ADA Highlights 2019 Editor

Jose C. Florez, MD, PhD
Chair, ADA Scientific Sessions Meeting Planning Committee


ADA Faculty Interviews

Leszek Czupryniak, MD, PhD
Warsaw Medical University, Warsaw, Poland

Ismaa Sadaf Farooqi, PhD
University of Cambridge, Cambridge, UK

Assiamira Ferrara, MD, PhD
Kaiser Permanente Northern California, Oakland, CA, USA

Elizabeth Mayer-Davis, PhD, MSPH, RD
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Peter Rossing, MD, DMSc
University of Copenhagen, Copenhagen, Denmark

Frank J. Snoek, PhD
Vrije Universiteit and University of Amsterdam, Amsterdam, The Netherlands

Virginia Valentine, APRN-CNS, BC-ADM, CDE, FAADE
Clinica La Esperanza, Albuquerque, NM, USA

James S. Wrobel, DPM, MS
University of Michigan, Ann Arbor, MI, USA


International Expert Interviews

Prof. Sof Andrikopoulos, PhD
CEO, Australian Diabetes Society
University of Melbourne, Melbourne, Australia

Hajar A. Ballout, MD
General secretary of Lebanese Society of Endocrinology and Diabetes and Lipids

Prof. Enzo Bonora
Università di Verona

Dra. Graciela V. Fuente
Presidente, Sociedad Argentina de Diabetes
Buenos Aires, Argentina

Dott. Stefano Genovese
Centro Cardiologico Monzino, IRCCS, Milano

Prof. Francesco Giorgino
Università degli Studi di Bari Aldo Moro

Prof. Linong Ji, MD
Peking University Diabetes Center, Beijing, China

Dra. Silvia Gorbán de Lapertosa 
Vice-Presidente, Sociedad Argentina de Diabetes
Buenos Aires, Argentina

Roger Lehmann, MD
University Hospital Zurich, Zürich

Dra. Hermelinda Pedrosa
Presidente, Sociedade Brasileira de Diabetes


Staff

Medical Writers

Marco Gallo, MD
Endocrine and Metabolic Complications of Cancer - Oncological Endocrinology
University Hospital “Città della Salute e della Scienza - Molinette”
Turin, Italy

Patrick Moore, PhD
Verona, Italy

ADA Reviewer

Matt Petersen
ADA Vice President of Medical Information

Project Managers

Thomas Lione
Natalia Lubomirski

Web Designer

Eugénie Munter

Web Developer

Riccardo Raneri

Web Management

Alice Lione

Project Assistant

Robyn Lynch

Video

Marco Antonelli

Editorial & Production Director

Giorgio Mantovani

Executive Manager

Rick Lione


Copyright: Infomedica

All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of Infomedica.

The content published in this website are the Highlights from the American Diabetes Association’s 79th Scientific Sessions (San Francisco, CA, June 7-11, 2019).

American Diabetes Association’s 79th Scientific Sessions content is made available to an international audience through a licensing agreement between Infomedica and the American Diabetes Association.

Powered by
Infomedica | Medical Education & Information
E-mail: info@infomedica.com
Website: www.infomedica.com


Disclaimer

In the course of covering medical congresses, Infomedica, the Publisher, may report on emerging technologies, techniques, and therapies. These reports may discuss drug and device applications that are either not approved by the appropriate regulatory body and/or the national or international Agency (Food and Drug Administration, European Medicines Agency, etc.) are not considered to be within the current standard guidelines for the practice of medicine. The Publisher does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of the information supplied nor for any opinion expressed in the publication. The Publisher, its agents, and employees will not be liable for any loss or damage arising directly or indirectly from the possession, publication, use of, or reliance on information obtained from the publication. It is provided in good faith without express or implied warranty. Reference to any specific commercial product or service does not imply endorsement or recommendation by the Publisher. In the interest of balance and transparency, no brand names are used in any of the reports. Commercial companies are not permitted any influence on editorial content. Advertisers and sponsors do not see editorial content prior to publication.